About Finoso Pharma
Finoso Pharma is a company based in Hyderabad (India) founded in 2009. It operates as a B2B. The company has 15 employees as of March 31, 2022. Finoso Pharma offers products and services including Formulation Development, Analytical Development, and Manufacturing Services. Finoso Pharma operates in a competitive market with competitors including WuXi AppTec, Eurofins Scientific, Ipsen, ANI Pharmaceuticals and Red Nucleus, among others.
- Headquarter Hyderabad, India
- Employees 15 as on 31 Mar, 2022
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Finoso Pharma Private Limited
- Date of Incorporation 18 Aug, 2009
- Jurisdiction Hyderabad, Telangana, India
-
Annual Revenue
$2.67 M (USD)71.24as on Mar 31, 2022
-
Net Profit
-$35.72 K (USD)39.87as on Mar 31, 2022
-
EBITDA
$189.26 K (USD)29.29as on Mar 31, 2022
-
Latest Funding Round
-
Investors
-
Employee Count
15
as on Mar 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Finoso Pharma
Finoso Pharma offers a comprehensive portfolio of products and services, including Formulation Development, Analytical Development, and Manufacturing Services.
Service for developing pharmaceutical formulations and processes.
Methods for assay and stability analysis of drug products.
Facilities for producing oral solids and liquids.
Funding Insights of Finoso Pharma
Investments & Acquisitions by Finoso Pharma
Financial Statements - Finoso Pharma
Finoso Pharma Comparisons
Competitors of Finoso Pharma
Finoso Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as WuXi AppTec, Eurofins Scientific, Ipsen, ANI Pharmaceuticals and Red Nucleus, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of CRO and CDMO services
|
|
| domain | founded_year | HQ Location |
Laboratory testing and contract research services are provided globally.
|
|
| domain | founded_year | HQ Location |
Biopharmaceutical company focused on developing and commercializing innovative treatments in oncology, rare disease, and neuroscience to improve patient health outcomes
|
|
| domain | founded_year | HQ Location |
Branded and generic prescription drugs are developed, manufactured, and marketed.
|
|
| domain | founded_year | HQ Location |
Advisory, scientific, and medical communications provided for pharmaceutical industry.
|
|
| domain | founded_year | HQ Location |
Regulatory support, brand differentiation, and prototyping services are provided.
|
Latest news on Finoso Pharma
Frequently Asked Questions about Finoso Pharma
Finoso Pharma was founded in 2009.
Finoso Pharma is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
As of Mar 31, 2022, the latest employee count at Finoso Pharma is 15.
Annual revenue of Finoso Pharma is $2.67M as on Mar 31, 2022.
Finoso Pharma is a services company specializing in formulation research and development for global pharmaceutical partners. It conducts activities like analytical development, process optimization, and regulatory filings. Based in Hyderabad, India, it serves clients in regulated markets through collaborative partnerships and high-quality manufacturing. The company focuses on precision and performance in drug development.
Finoso Pharma's top competitors include WuXi AppTec, ANI Pharmaceuticals and Aptar.
Finoso Pharma offers Formulation Development, Analytical Development, and Manufacturing Services.